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Coenzyme Q (CoQ) plays an important role as an electron transporter in the respiratory chain. It is formed from 
a benzoquinone ring and an isoprenoid chain of a specific length depending on the organism. CoQ10 has been 
used in the treatment of different diseases including Parkinsons, Alzheimer and cardiovascular diseases. In 
addition, it is used as a dietary supplement and in cosmetic applications due to its important antioxidant 
property. Escherichia coli produces CoQ8 naturally but it is able to produce CoQ10 when an heterologous 
decaprenyl synthase is expressed. E. coli is easy to culture and relatively easy to modify genetically which 
makes it suitable for the development of an industrial-scale process. In a previous work, we constructed strains 
unable to produce demethylmenaquinone (DMK) and menaquinone (MK), compounds that compete for both 
chorismate, precursor of the benzoquinone ring, and the isoprenoid chain. In addition, mutant strains unable to 
produce enterobactin, high affinity siderophore, synthesized from chorismate, were also constructed. These 
strains where designed as platforms for the generation of novel CoQ-producing strains. In the present work, the 
production of CoQ was assessed in the mentioned strains at several culture conditions including the use of 
different carbon sources (glucose, glycerol and succinate) and different culture strategies (batch and 
continuous) in a Lab-Scale Bioreactor.   
 
